Aurobindo Pharma Limited (BOM:524804)

Aurobindo Pharma Statistics

Total Valuation

BOM:524804 has a market cap or net worth of INR 647.68 billion. The enterprise value is 663.34 billion.

Market Cap	647.68B
Enterprise Value	663.34B

Important Dates

The last earnings date was Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.48%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	272.89M

Valuation Ratios

The trailing PE ratio is 18.55.

PE Ratio	18.55
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	19.00
EV / Sales	2.15
EV / EBITDA	10.01
EV / EBIT	13.27
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.27
Debt / EBITDA	1.27
Debt / FCF	n/a
Interest Coverage	12.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	8.45%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	11.89M
Profits Per Employee	1.34M
Employee Count	26,015
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.96%
50-Day Moving Average	1,208.40
200-Day Moving Average	1,323.67
Relative Strength Index (RSI)	40.18
Average Volume (20 Days)	21,578

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524804 had revenue of INR 309.22 billion and earned 34.91 billion in profits. Earnings per share was 59.81.

Revenue	309.22B
Gross Profit	178.80B
Operating Income	50.11B
Pretax Income	49.61B
Net Income	34.91B
EBITDA	65.72B
EBIT	50.11B
Earnings Per Share (EPS)	59.81

Balance Sheet

The company has 68.68 billion in cash and 84.27 billion in debt, giving a net cash position of -15.59 billion.

Cash & Cash Equivalents	68.68B
Total Debt	84.27B
Net Cash	-15.59B
Net Cash Per Share	n/a
Equity (Book Value)	308.85B
Book Value Per Share	528.88
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 57.82%, with operating and profit margins of 16.21% and 11.29%.

Gross Margin	57.82%
Operating Margin	16.21%
Pretax Margin	16.04%
Profit Margin	11.29%
EBITDA Margin	21.25%
EBIT Margin	16.21%
FCF Margin	n/a

Dividends & Yields

BOM:524804 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.48%
Shareholder Yield	0.48%
Earnings Yield	5.39%
FCF Yield	n/a

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 20, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a